Reena Chawla is a prominent inventor based in Tucson, AZ (US). She has made significant contributions to the field of medicinal chemistry, particularly through her innovative research and development of small molecule antagonists.

Latest Patents

Reena Chawla holds a total of 4 patents. Her latest patents include "Small molecule antagonists of sumo related modification of CRMP2 and uses thereof." This invention focuses on a new class of small molecules with a piperidinyl-benzoimidazole structure that act as antagonists of SUMOylation of collapsin response mediator protein 2 (CRMP2). These compounds are designed for therapeutic applications in treating conditions related to voltage-gated sodium channel 1.7 (Nav1.7), such as itch, anosmia, migraine events, and neuropathic pain. Another notable patent is "CRMP2 sumoylation inhibitors and uses thereof," which provides compounds that modulate the presence of Nav1.7 protein on the cellular surface, offering potential treatments for various clinical conditions.

Career Highlights

Reena Chawla has worked with esteemed institutions, including the University of Arizona and the Arizona Board of Regents on behalf of the University. Her work has been instrumental in advancing the understanding and treatment of pain signaling mechanisms.

Collaborations

Throughout her career, Reena has collaborated with notable colleagues, including Vijay Gokhale and May Khanna. These partnerships have contributed to her innovative research and the successful development of her patents.

Conclusion

Reena Chawla's contributions to medicinal chemistry and her innovative patents highlight her role as a leading inventor in her field. Her work continues to pave the way for new therapeutic approaches to pain management and related conditions.

This text is generated by artificial intelligence and may not be accurate.